Literature DB >> 10482926

Role of shear stress in nitric oxide-dependent modulation of renal angiotensin II vasoconstriction.

K Endlich1, C Muller, M Barthelmebs, J J Helwig.   

Abstract

1. Renal vasoconstriction in response to angiotensin II (ANGII) is known to be modulated by nitric oxide (NO). Since shear stress stimulates the release of a variety of vasoactive compounds from endothelial cells, we studied the impact of shear stress on the haemodynamic effect of ANGII in isolated perfused kidneys of rats under control conditions and during NO synthase inhibition with L-NAME (100 microM). 2. Kidneys were perfused in the presence of cyclo-oxygenase inhibitor (10 microM indomethacin) with Tyrode's solution of relative viscosity zeta=1 (low viscosity perfusate, LVP) or, in order to augment shear stress, with Tyrode's solution containing 7% Ficoll 70 of relative viscosity zeta=2 (high viscosity perfusate, HVP). 3. Vascular conductance was 3.5+/-0.4 fold larger in HVP as compared with LVP kidneys, associated with an augmentation of overall wall shear stress by 37+/-5%. During NO inhibition, vascular conductance was only 2.5+/-0.2 fold elevated in HVP vs LVP kidneys, demonstrating shear stress-induced vasodilatation by NO and non-NO/non-prostanoid compound(s). 4. ANGII (10 - 100 pM) constricted the vasculature in LVP kidneys, but was without effect in HVP kidneys. During NO inhibition, in contrast, ANGII vasoconstriction was potentiated in HVP as compared with LVP kidneys. 5. The potentiation of ANGII vasoconstriction during NO inhibition has been shown to be mediated by endothelium-derived P450 metabolites and to be sensitive to AT2 receptor blockade in our earlier studies. Accordingly, in HVP kidneys, increasing concentrations of the AT2 receptor antagonist PD123319 (5 and 500 nM) gradually abolished the potentiation of ANGII vasoconstriction during NO inhibition, but did not affect vasoconstriction in response to ANGII in LVP kidneys. 6. Our results demonstrate, that augmentation of shear stress by increasing perfusate viscosity induces vasodilatation in the rat kidney, which is partially mediated by NO. Elevated levels of shear stress attenuate renal ANGII vasoconstriction through enhanced NO production and are required for AT2 sensitive potentiation during NO inhibition.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10482926      PMCID: PMC1566183          DOI: 10.1038/sj.bjp.0702739

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  38 in total

Review 1.  Blood viscosity in tube flow: dependence on diameter and hematocrit.

Authors:  A R Pries; D Neuhaus; P Gaehtgens
Journal:  Am J Physiol       Date:  1992-12

2.  Endothelium-dependent, flow-induced dilation of isolated coronary arterioles.

Authors:  L Kuo; M J Davis; W M Chilian
Journal:  Am J Physiol       Date:  1990-10

3.  EDRF-mediated shear-induced dilation opposes myogenic vasoconstriction in small rabbit arteries.

Authors:  U Pohl; K Herlan; A Huang; E Bassenge
Journal:  Am J Physiol       Date:  1991-12

4.  Effects of dextran-induced hyperviscosity on regional blood flow and hemodynamics in dogs.

Authors:  R Y Chen; R D Carlin; S Simchon; K M Jan; S Chien
Journal:  Am J Physiol       Date:  1989-03

5.  Prostaglandins mediate arteriolar dilation to increased blood flow velocity in skeletal muscle microcirculation.

Authors:  A Koller; G Kaley
Journal:  Circ Res       Date:  1990-08       Impact factor: 17.367

6.  Endothelium modulates renal blood flow but not autoregulation.

Authors:  W H Beierwaltes; D H Sigmon; O A Carretero
Journal:  Am J Physiol       Date:  1992-06

7.  Modulation of angiotensin II-induced vasoconstriction by endothelium-derived relaxing factor in the isolated microperfused rabbit afferent arteriole.

Authors:  S Ito; C S Johnson; O A Carretero
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

8.  Endothelium-derived relaxing factor/nitric oxide modulates angiotensin II action in the isolated microperfused rabbit afferent but not efferent arteriole.

Authors:  S Ito; S Arima; Y L Ren; L A Juncos; O A Carretero
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

9.  Angiotensin dependence of endothelium-mediated renal hemodynamics.

Authors:  D H Sigmon; O A Carretero; W H Beierwaltes
Journal:  Hypertension       Date:  1992-11       Impact factor: 10.190

10.  AT2 antagonist-sensitive potentiation of angiotensin II-induced constriction by NO blockade and its dependence on endothelium and P450 eicosanoids in rat renal vasculature.

Authors:  C Muller; K Endlich; J J Helwig
Journal:  Br J Pharmacol       Date:  1998-07       Impact factor: 8.739

View more
  3 in total

1.  Cyclic gmp is a measure of physiologic stress.

Authors:  K A Hunter; G J Singh; C O Simpkins
Journal:  J Natl Med Assoc       Date:  2001 Jul-Aug       Impact factor: 1.798

2.  Functional role of angiotensin II AT2 receptor in modulation of AT1 receptor-mediated contraction in rat uterine artery: involvement of bradykinin and nitric oxide.

Authors:  Ruth E Hannan; Elizabeth A Davis; Robert E Widdop
Journal:  Br J Pharmacol       Date:  2003-10-06       Impact factor: 8.739

3.  Complement Activation in Patients With Diabetic Nephropathy.

Authors:  Pascal Bus; Jamie S Chua; Céline Q F Klessens; Malu Zandbergen; Ron Wolterbeek; Cees van Kooten; Leendert A Trouw; Jan A Bruijn; Hans J Baelde
Journal:  Kidney Int Rep       Date:  2017-10-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.